The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Environment and Cancer: Who Are Susceptible?
Abstract
Acting in concert with individual susceptibility, environmental factors such as smoking, diet, and pollutants play a role in most human cancer. However, new molecular evidence indicates that specific groups—characterized by predisposing genetic traits or ethnicity, the very young, and women—may have heightened risk from certain exposures. This is illustrated by molecular epidemiologic studies of environmental carcinogens such as polycyclic aromatic hydrocarbons and aromatic amines. Individual genetic screening for rare high-risk traits or for more common, low-penetrant susceptibility genes is problematic and not routinely recommended. However, knowledge of the full spectrum of both genetic and acquired susceptibility in the population will be instrumental in developing health and regulatory policies that increase protection of the more susceptible groups from risks of environmental carcinogens. This will necessitate revision of current risk assessment methodologies to explicitly account for individual variation in susceptibility to environmental carcinogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Migration Patterns and Breast Cancer Risk in Asian-American Women
Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M. Y., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-Ross, P. L., Rosenthal, J. F., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.22.1819 · Cited by 1,098
Differences in Lung Cancer Risk Between Men and Women: Examination of the Evidence
Zang, E. A., & Wynder, E. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.183 · Cited by 722
Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., & Lucier, G. W. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1159 · Cited by 697
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Breast Cancer and Serum Organochlorines: a Prospective Study Among White, Black, and Asian Women
Krieger, N., Wolff, M. S., Hiatt, R. A., Rivera, M., Vogelman, J., & Orentreich, N. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.8.589 · Cited by 492
Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340302 · Cited by 385
Wagenknecht, L. E., Burke, G. L., Perkins, L. L., Haley, N. J., & Friedman, G. D. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.1.33 · Cited by 374
Cited by
Santos, A. G., da Rocha, G. O., & de Andrade, J. B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37186-2 · Cited by 8,495
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
INDUCTION OF CYTOCHROME P4501A1
Whitlock, J. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.103 · Cited by 1,124
Shen, H., Huang, Y., Wang, R., Zhu, D., Li, W., Shen, G., Wang, B., Zhang, Y., Chen, Y., Lu, Y., et al. (2013) · Environmental Science & Technology · doi:10.1021/es400857z · Cited by 833
LEWTAS, J. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.003 · Cited by 685
Ma, Y., Huang, A., Cao, S., Sun, F., Wang, L., Guo, H., & Ji, R. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.10.061 · Cited by 616
“…tracer and chose phenanthrene (Phe) as a model compound of PAHs, which have significant carcinogenic and mutagenic toxicity to organisms (Perera, 1997; Zhang et al., 2009), to investigate the combined toxicity of FPs and PAHs, and the effects of MPs and NPs on the transformation and…”
BackgroundMethodGenomic profiling of drug sensitivities via induced haploinsufficiency
Giaever, G., Shoemaker, D. D., Jones, T. W., Liang, H., Winzeler, E. A., Astromoff, A., & Davis, R. W. (1999) · Nature Genetics · doi:10.1038/6791 · Cited by 570
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention
Hecht, S. S. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00815-x · Cited by 536
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Arlt, V. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.4.265 · Cited by 505
Germline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
WHITESIDE, T. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.008 · Cited by 487
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 424
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Hecht, S. S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.907 · Cited by 404
Height, Leg Length, and Cancer Risk: A Systematic Review
Gunnell, D., Okasha, M., Davey Smith, G., Oliver, S. E., Sandhu, J., & Holly, J. M. P. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000809 · Cited by 403
Twin Studies of Psychiatric Illness: An Update
Kendler, K. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1005 · Cited by 382
Can family history be used as a tool for public health and preventive medicine?
Yoon, P. W., Scheuner, M. T., Peterson-Oehlke, K. L., Gwinn, M., Faucett, A., & Khoury, M. J. (2002) · Genetics in Medicine · doi:10.1097/00125817-200207000-00009 · Cited by 371
Lifestyle-related factors and environmental agents causing cancer: An overview
Irigaray, P., Newby, J. A., Clapp, R., Hardell, L., Howard, V., Montagnier, L., Epstein, S., & Belpomme, D. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.10.006 · Cited by 368
Detailed review of transgenic rodent mutation assays
Lambert, I. B., Singer, T. M., Boucher, S. E., & Douglas, G. R. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2005.04.002 · Cited by 360
Universal DNA microarray method for multiplex detection of low abundance point mutations
Gerry, N. P., Witowski, N. E., Day, J., Hammer, R. P., Barany, G., & Barany, F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3063 · Cited by 346
Greenwald, P., Clifford, C. K., & Milner, J. A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00070-3 · Cited by 337
Perspectives on Cancer Chemoprevention Research and Drug Development
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61026-x · Cited by 317
Per- and Polyfluoroalkyl Substances (PFAS) in Breast Milk: Concerning Trends for Current-Use PFAS
Zheng, G., Schreder, E., Dempsey, J. C., Uding, N., Chu, V., Andres, G., Sathyanarayana, S., & Salamova, A. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c06978 · Cited by 316
Chou, C.-C., Yang, J.-S., Lu, H.-F., Ip, S.-W., Lo, C., Wu, C.-C., Lin, J.-P., Tang, N.-Y., Chung, J.-G., Chou, M.-J., et al. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0808-y · Cited by 310
From genotype to phenotype: buffering mechanisms and the storage of genetic information
Rutherford, S. L. (2000) · BioEssays · doi:10.1002/1521-1878(200012)22:12<1095::aid-bies7>3.0.co;2-a · Cited by 284
Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions
Shields, P. G., & Harris, C. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2309 · Cited by 275
Second cancers in survivors of childhood cancer
Bhatia, S., & Sklar, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc722 · Cited by 268
Activation of procarcinogens by human cytochrome P450 enzymes
Peter Guengerich, F., & Shimada, T. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00037-2 · Cited by 260
Therapy-related leukemia and myelodysplasia: susceptibility and incidence
Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T. (2007) · Haematologica · doi:10.3324/haematol.11034 · Cited by 236
Schwartz, S., Susser, E., & Susser, M. (1999) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.20.1.15 · Cited by 148
Outdoor air pollution, green space, and cancer incidence in Saxony: a semi-individual cohort study
Datzmann, T., Markevych, I., Trautmann, F., Heinrich, J., Schmitt, J., & Tesch, F. (2018) · BMC Public Health · doi:10.1186/s12889-018-5615-2 · Cited by 141
Davey Smith, G. (2011) · Genes & Nutrition · doi:10.1007/s12263-010-0181-y · Cited by 134
Singh, V. K., Patel, D. K., Jyoti, Ram, S., Mathur, N., & Siddiqui, M. K. J. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.11.017 · Cited by 94
Kim, E.-Y., & Hahn, M. E. (2002) · Aquatic Toxicology · doi:10.1016/s0166-445x(01)00221-1 · Cited by 22
Metadata
- Authors
- Perera, F. P.
- Venue
- Science
- Published
- 1997-11-07
- Volume
- 278
- Issue
- 5340
- Pages
- 1068-1073
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1989108484
- Cited by
- 638
- References
- 33
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.